Detalhe da pesquisa
1.
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting.
Br J Haematol
; 190(6): 891-900, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239670
2.
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Blood
; 141(21): 2657-2661, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898087
3.
Absence of leukaemic CD34+ cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered.
Br J Haematol
; 171(2): 227-238, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26104974
4.
Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults.
Br J Haematol
; 186(1): 130-133, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520018
5.
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(10): 1754-60, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24976003
6.
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia.
Leukemia
; 38(3): 630-639, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272991
7.
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry.
Cytometry B Clin Cytom
; 104(6): 426-439, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766649
8.
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML.
Cancers (Basel)
; 13(11)2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073205
9.
MRD Tailored Therapy in AML: What We Have Learned So Far.
Front Oncol
; 10: 603636, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33575214
10.
Activin-A Induces Fewer, but Larger Osteoclasts From Monocytes in Both Healthy Controls and Fibrodysplasia Ossificans Progressiva Patients.
Front Endocrinol (Lausanne)
; 11: 501, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32760351
11.
Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.
Haematologica
; 94(1): 46-53, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19042917
12.
Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Stem Cells
; 26(12): 3059-67, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19096043
13.
Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.
Curr Protoc Cytom
; 91(1): e66, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31763792
14.
Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
Leuk Res
; 81: 27-34, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002948
15.
Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
Leuk Res
; 76: 39-47, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30553189
16.
CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia.
Leukemia
; 33(5): 1102-1112, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30542144
17.
Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.
J Clin Periodontol
; 35(7): 568-75, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18435789
18.
Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization.
Expert Rev Hematol
; 11(12): 921-935, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30466339
19.
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML.
Hemasphere
; 7(12): e981, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026789
20.
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia.
J Vis Exp
; (133)2018 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29553571